- Papers in database
- 9
- Primary author
- 2 papers
- Years active
- 2012 – 2025
Papers (9)
- 2025A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.10.1007/s00198-025-07650-7
- 2020Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.10.3390/nu12072041
- 2019Primary authorGut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia10.3390/microorganisms7080228
- 2018Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis.10.1177/1534735418794885
- 2017Primary authorAdjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.10.3390/vaccines5040050
- 2015Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions.10.1007/978-3-0348-0927-6_3
- 2013Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles.10.1007/s10787-012-0146-4
- 2013A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.10.1016/j.ctim.2013.01.007
- 2012Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study.10.1007/s10787-012-0128-6